Anti-Human IgG (H+L) - 50nm Silver Conjugate
Cytodiagnostics
SKU:SC-50-03-05
Couldn't load pickup availability

Anti-Human IgG (H+L) - 50nm Silver Conjugate for silver nanoparticle detection
Anti-Human IgG (H+L) - 50nm Silver Conjugate supports method development where human IgG (H+L) must be detected in Immunoblotting, Electron Microscopy and Lateral Flow Assay. It helps researchers evaluate target fit, assay readout and control strategy before selecting a related label or antibody format.
Scientific fit
The silver nanoparticle label is useful when a bright silver-based optical readout is preferred over a traditional gold readout. This larger silver label supports stronger visual contrast in workflows where signal strength is more important than minimal particle size.
Protocol notes
- Fits workflows that require clear Human IgG (H+L) detection and a reagent choice that can be documented consistently.
- Useful during assay development when conjugate signal, membrane migration and background must be tuned together.
- Include matched negative controls and optimize blocking to separate true target-associated signal from nonspecific particle binding.
Reference SC-50-03-05 in protocols, purchasing notes and internal reagent libraries when matching this product to your chosen assay. This makes the reagent easier to evaluate during assay planning, troubleshooting and method transfer.
- Research Area:
- Immunology • Nanotechnology & Biosensors • Assay Development
- Application:
- Immunoblotting • Electron Microscopy • Lateral Flow Assay
- Reactivity:
- Human
- Host:
- Goat
- Clonality:
- Polyclonal
- Isotype:
- IgG
- Formulation:
- 20mM Tris (pH 8.0), 150mM NaCl, 20% glycerol (v/v), 1% BSA
- Adsorption Max:
- 415-430nm
- Core Size:
- 50nm
- Shape:
- Spherical
- Material:
- Silver
- Storage Temperature:
- 4°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.